drugset / Trial / NCT01994083

A Study of Multiple Oral Doses of IX-01 in Healthy Men

NCT01994083 ↗

Phase 1 Completed 48 enrolled Ixchelsis Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of IX-01 after multiple doses, and to determine how the body handles IX-01.

Timeline

Start
2013-11
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject IX-01 Unknown — Oral

Indications

No indication recorded.